RGLS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Regulus Therapeutics (RGLS) Earnings Date & Reports

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

RGLS is expected to report earnings to rise 95.53% to -29 cents per share on August 12

Regulus Therapeutics RGLS Stock Earnings Reports

Q2'25

Est.

$-0.29

Q1'25

Beat

by $0.10

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.04

Q2'24

Missed

by $0.05

The last earnings report on May 08 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 1.65M shares outstanding, the current market capitalization sits at 544.53M.

View a ticker or compare two or three

Compare

RGLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGLS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RGLS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

4224 Campus Point Court

Phone

+1 858 202-6300

Employees

Web

https://www.regulusrx.com